title: Current Clinical Practice Scenario of Osteoporosis Management in India.
abstract: BACKGROUND
  Various osteoporosis guidelines are available for practice.
  
  
  OBJECTIVE
  To understand the current clinical practice scenario from the perspective of Indian orthopaedicians, especially about the epidemiology, clinical manifestations, approach to diagnosis and management and patient compliance patterns to long term treatment.
  
  
  METHODS
  A pre-validated structured questionnaire containing questions (mostly objective, some open-ended) catering to various objectives of the study was circulated amongst orthopaedic surgeons across India by means of post/courier, after giving a brief overview of the study telephonically. Data was extracted from the completed questionnaires, and analysed using Microsoft Excel software.
  
  
  RESULTS
  The questionnaire was filled by a total of 84 orthopaedicians throughout India. The prevalence of osteoporosis in India according to the orthopaedic surgeons was 38.4% and there was a female preponderance. Most of the respondents felt out of every 100 osteoporosis patients in India, less than 20 patients are actually diagnosed and treated for osteoporosis. The most common initial presenting feature of established osteoporosis cases was general symptoms. Most respondents preferred Dual-energy X-ray absorptiometry (DEXA) as the initial investigation for the diagnosis of osteoporosis in a patient presenting with typical features. While most respondents preferred once-a-month oral over intravenous (IV) bisphosphonates, they agreed that IV administration had advantages such as lower gastrointestinal side effects and improved compliance. The average duration of therapy of oral bisphosphonates was the longest (27.04 months) among the other anti- osteoporosis therapies that they used. On an average, the patient compliance rate in osteoporosis management was around 64%. IV Zoledronic acid (ZA) and intranasal calcitonin were infrequently used than other anti- osteoporosis therapies. While concerns about cost and availability deterred more frequent usage, there was an agreement that if used regularly these two agents may improve compliance rates among patients.
  
  
  CONCLUSIONS
  Current clinical practice scenario of osteoporosis management in India largely adheres to various clinical practice guidelines for osteoporosis. Side effects and lengthy duration of therapy with bisphosphonates seem to be the main factors leading to a low patient compliance. Widespread popularization of once-yearly Zoledronic acid and intranasal calcitonin spray may improve patient compliance and reduce side effect incidence.
authors.affiliation: Consultant, Department of Orthopedics, Jaslok Hospital & Research Centre , Mumbai, India .
authors.forename: Shailesh
authors.initials: S
authors.lastname: Jhaveri
authors.affiliation: Consultant, Department of Orthopedics, Fortis Hospital , Mumbai, India .
authors.forename: Tejas
authors.initials: T
authors.lastname: Upashani
authors.affiliation: Medical Advisor, Abbott Healthcare Pvt. Ltd. , Mumbai, India .
authors.forename: Jitendra
authors.initials: J
authors.lastname: Bhadauria
authors.affiliation: Medical Advisor, Abbott Healthcare Pvt. Ltd. , Mumbai, India .
authors.forename: Swati
authors.initials: S
authors.lastname: Biswas
authors.affiliation: Head Medical, Abbott Healthcare Pvt. Ltd. , Mumbai, India .
authors.forename: Kamlesh
authors.initials: K
authors.lastname: Patel
keywords: Bisphosphonates; Calcitonin; Compliance; Osteoporosis; Zoledronate